loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Diindolylmethane

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Diindolylmethane

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 57Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Body Plus Nutritional Products Inc Recalls of Precision Extreme Mega Test
    Body Plus Nutritional Products Inc Recalls of Precision Extreme Mega Test

    19 Apr 2017

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/body-plus-nutritional-products-inc-recalls-of-precision-extreme-mega-test-1492664564.pdf

    HEALTH CANADA
    19 Apr 2017
    Share Share
    Can a Pill Offer the Same Cancer Benefits as Broccoli?
    Can a Pill Offer the Same Cancer Benefits as Broccoli?

    06 Apr 2015

    // Laura Johannes THE WALL STREET JOURNAL

    http://www.wsj.com/articles/can-a-pill-offer-the-same-cancer-benefits-as-broccoli-1428337783

    Laura Johannes THE WALL STREET JOURNAL
    06 Apr 2015
    Share Share